Tanja Stamm

2002–2026 年に発表

134
論文数
21,024
被引用数
63
h 指数
123
i10 指数

被引用数

Tanja Stamm の年別被引用数2003 年: 被引用 1 件2004 年: 被引用 6 件2005 年: 被引用 17 件2006 年: 被引用 18 件2007 年: 被引用 35 件2008 年: 被引用 39 件2009 年: 被引用 58 件2010 年: 被引用 74 件2011 年: 被引用 78 件2012 年: 被引用 69 件2013 年: 被引用 58 件2014 年: 被引用 87 件2015 年: 被引用 120 件2016 年: 被引用 122 件2017 年: 被引用 142 件2018 年: 被引用 144 件2019 年: 被引用 647 件2020 年: 被引用 734 件2021 年: 被引用 635 件2022 年: 被引用 546 件2023 年: 被引用 448 件2024 年: 被引用 980 件2025 年: 被引用 400 件2026 年: 被引用 19 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,249 件、この内訳の 12.3%イギリス: 引用元論文 922 件、この内訳の 9.1%オランダ: 引用元論文 623 件、この内訳の 6.1%ドイツ: 引用元論文 608 件、この内訳の 6%イタリア: 引用元論文 571 件、この内訳の 5.6%フランス: 引用元論文 493 件、この内訳の 4.8%中国: 引用元論文 473 件、この内訳の 4.7%カナダ: 引用元論文 373 件、この内訳の 3.7%日本: 引用元論文 370 件、この内訳の 3.6%オーストリア: 引用元論文 359 件、この内訳の 3.5%スペイン: 引用元論文 351 件、この内訳の 3.5%オーストラリア: 引用元論文 270 件、この内訳の 2.7%
0%12.3%その他 34.4%

分野

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Immunology and Microbiology4.8%
  • Health Professions2.2%
  • Social Sciences1.5%
  • Dentistry1.5%
  • その他4.2%

トピック

  • Rheumatoid Arthritis Research and Therapies20.4%
  • Spondyloarthritis Studies and Treatments8.2%
  • Autoimmune and Inflammatory Disorders Research5.9%
  • Systemic Lupus Erythematosus Research4.7%
  • Psoriasis: Treatment and Pathogenesis2.6%
  • Osteoarthritis Treatment and Mechanisms2.1%
  • その他56.1%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 被引用: 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 5,775

  3. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Robert Landewé, E. Martín‐Mola, Peter Nash, Mikkel Østergaard, Andrew J.K. Östör, P. Scott Richards, Tuulikki Sokka‐Isler, Carter Thorne, Athanasios G. Tzioufas, Ronald van Vollenhoven, M. De Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2015 被引用: 1,458

  4. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher T. Ritchlin, Martín Rudwaleit, Adrian Tanew, Bing Thio, Douglas J. Veale, Kurt de Vlam, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 676

  5. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 168

  6. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    著者: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 241

  7. 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    著者: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 被引用: 493

  8. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 139

  9. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

    著者: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2021 被引用: 309

  10. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 116

  11. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

    著者: , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 131

  12. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 120

  13. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

    著者: , , , , , , - Arthritis Research & Therapy 2005 被引用: 1,076

  14. Consensus recommendations on how to assess the quality of surgical interventions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Pascale Pomey, Susan M. Webb, Panel 2, Felix Berlth, J.M. Ramia, Roxane D. Staiger, Kathy Sienko, Marit S. de Vos, Henrik Kehlet, Philip C. Müller, Panel 3, Martin F. Fey, Susan O’Reilly, René Vonlanthen, Panel 4, Andrew C. von Eschenbach, Jeffrey V. Lazarus, Zeynep Or, Clifford Y. Ko, Panel 5, Mia Aurelia Huber, Jonathan Ives, Tanja Krones, Robert D. Truog, Sridhar Venkatapuram, Panel 6, Jad Abou‐Khalil, Julio F. Fiore, Cesar A. Hincapié, Norihiro Kokudo, Timothy M. Pawlik, Panel 7, Mark Adams, Joel Armitage, Anne Lübbeke, Patricia Sánchez‐Velázquez, Reto A. Schuepbach, Alicja Zientara, Marit Kalisvaart, Daniel A. Hofmaenner, Jean‐Daniel Chiche, Alexander Jackson, Ramani Moonesinghe, Panel 8, Fariba Abbassi, Bernice S. Elger, Alexander Joeris, Fabia Rothenfluh, Felix Schneuwly, Yuki Seidler, Guru Sivaraman, Panel 9, Tala Ballouz, Ana Costa-Ramón, Rebecca A. Snyder, Mirriam Tyebally Fang, Claudia M. Witt - Nature Medicine 2023 被引用: 93

  15. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen - Annals of the Rheumatic Diseases 2022 被引用: 69

  16. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 133

  17. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 被引用: 421

  18. RECOMMENDATIONS FOR USE AND SCORING OF ORAL HEALTH IMPACT PROFILE VERSIONS

    著者: , , , , , , , , , , , , , , , , , - Journal of Evidence Based Dental Practice 2021 被引用: 124

  19. Determinants of COVID-19 vaccine fatigue

    著者: , , , , , , - Nature Medicine 2023 被引用: 82

  20. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 103

  21. The Roadmap for Implementing Value-Based Healthcare in European University Hospitals—Consensus Report and Recommendations

    著者: , , , , , , , , , , , , , , , - Value in Health 2021 被引用: 73

  22. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    著者: , , , , , , , , , , , , , , , , , , - RMD Open 2022 被引用: 71

  23. Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states

    著者: , , , , , - Arthritis & Rheumatism 2005 被引用: 548

  24. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    著者: , , , , , , , , , , , , , , , , , , - RMD Open 2022 被引用: 84